
|Articles|May 21, 2007
Latebreakers: Transdermal option given OK for Parkinson's disease
A unique delivery for a new dopamine agonist has been approved to treat symptoms of early Parkinson's disease (PD).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage
2
Wegovy Pill Receives FDA Approval as First Oral GLP-1 for Weight-Loss
3
CoronaVac Improves Outcomes of COVID-19 for Patients With Schizophrenia
4
Women’s Health: Top Stories of 2025
5
















































































































